Nanomedicine Innovation Network

Precision Nanosystems Presents:



in a Pandemic

2020 Virtual Nanomedicine Symposium


Thank you to all the participants, look for our next Symposium coming next fall. 

With over 800 attendees, 300 questions asked and answered, and 13 speakers, you made PNI's first Virtual Nanomedicine Symposium a great success!


We will be sending out links to the sessions in the first week of August for those who attended the symposium and would like links to the recorded sessions. 


If you could not attend the and would like to learn more about nanomedicine and view the recordings from the symposium, please fill out the form below, and we will be in touch with you.

Example of past symposium schedules:


July 23, 2020

 Time Zones Program Schedule


July 23, 2020

Brief Schedule




Session 1: RNA Treatments and Vaccines for Infectious Disease Response



Opening remarks discussing the current landscape and the opportunities RNA treatments compared to DNA and conventional vaccines. Further discussion from other speakers will cover important development and regulatory topics.


Speakers: Dr. Yvonne PerrieDr. Andy Geall, Dr. Lloyd Jeffs,  Dr. Bijoyita Roy






Session 2: RNA and Delivery Platform Technologies




Choose one of four 45 minute breakout presentations covering in-depth technical topics in RNA medicine.


Breakout A: Understanding the Basics of mRNA Transcription and the Path to GMP mRNA Manufacturing, Basics of RNA and RNA vaccines—Sourcing enzymes IVT

Speakers: Dr. Bijoyita Roy, Dr. G Brett Robb,

Dr. Anton McCaffrey


Breakout B: Introduction to RNA Delivery Technologies 

Speaker: Dr. Gaurav Sahay

Breakout C: Antigen Design Strategies

Speaker: Annie Dosey

Breakout D: Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA vaccines

Speaker: Dr. Luis Brito







Session 3: RNA Vaccine Demonstration




Recreating formulations used in proof-of-concept studies in 2012 (Geall et al.) which was the first PoC demonstration of RNA-LNP vaccine, this time, using the NanoAssemblr® Platform, including the GMP System


Speakers: Dr. Andy Geall, Dr. Shell Ip






Session 4: Manufacturing Platform Technology—Panel Discussion



Presentation on the evolution of various approaches to lipid nanoparticle production, the basics of microfluidic self-assembly and the benefits to future scale up. A panel discussion will take place discussing how PNI can take care of Lipids and LNPs for GMP manufacturing


Concluding remarks will be given about the implications of COVID-19 for RNA medicines


Speakers: Dr. Frank Slack, Dr. Suraj Abraham, Jessica Madigan, previous session speakers